Gabapentin Capsule
Product Images NDC 70518-1760

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70518-1760). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Gabapentin 300mg 70518 1760 01)

Gabapentin 300 mg capsule label showing a quantity of 90 capsules. The label includes the NDC number 70518-1760-01, repackaged by RemedyRepack Inc. The manufacturer is listed as Ascend Labs, LLC, Montvale, NJ. Directions for use refer to the package insert. Storage instructions and contact information for RemedyRepack are also present.*

FDA Label Image

Mm3 (Gabapentin 300mg 70518 1760 02)

Gabapentin 300 mg capsules packaged in a quantity of 60. The label features the Remedy Repack logo and indicates repackaging by RemedyRepack Inc., Indiana, PA. The label includes storage instructions and manufacturer information for Ascend Labs, LLC, Montvale, NJ. The product is prescription only (RX only).*

FDA Label Image

Mm4 (Gabapentin 300mg 70518 1760 03)

Gabapentin 300 mg capsule label showing a quantity of 30 capsules. The label includes the NDC number 70518-1760-03, manufacturer Ascend Labs, LLC, Montvale, NJ, and repackager RemedyRepack Inc., Indiana, PA. Directions and storage instructions are indicated to be in the package insert.*

FDA Label Image

Gabapentin 300mg 70518 1760 04

Label for Gabapentin 300 mg capsules with a quantity of 30. The label includes NDC number 70518-1760-04 and states the product is repackaged by RemedyRepack Inc. It advises storing the medication at controlled room temperature and to see the package insert for directions. Manufacturer is Ascend Labs, LLC, Montvale, NJ.*

FDA Label Image

Gabapentin 300mg 70518 1760 05

Gabapentin 300 mg oral capsules packaging label showing quantity of 60 capsules. The label indicates repackaging by RemedyRepack Inc. with directions to see the package insert. Manufacturer listed as Ascend Labs, LLC, Montvale, NJ. Label includes NDC 70518-1760-05 and storage instructions at 20-25°C with excursions permitted between 15-30°C.*

FDA Label Image

Gabapentin 300mg 70518 1760 06

Gabapentin 300 mg oral capsules in a package containing 90 capsules. The label shows the product is repackaged by RemedyRepack Inc., with directions to see the package insert for use. The label includes storage instructions, a QR code, and caution to keep medication out of reach of children.*

FDA Label Image

Gabapentin 300mg 70518 1760 07

Gabapentin 300 mg capsule label showing quantity of 180 capsules. The label includes the NDC number 70518-1760-07 and states the manufacturer as Ascend Labs, LLC, Montvale, NJ. It contains storage instructions and notes repackaging by RemedyRepack Inc., Indiana, PA. The label prominently displays the RemedyRepack logo and RX ONLY designation.*

FDA Label Image

Gabapentin 300mg 70518 1760 08

Gabapentin 300 mg oral capsules label repackaged by RemedyRepack Inc. The label indicates a quantity of 120 capsules and includes storage instructions and manufacturer information from Ascend Labs, LLC, Montvale, NJ. The label displays the NDC number 70518-1760-08 along with a QR code and states 'Rx Only.'*

FDA Label Image

Gabapentin 300mg 70518 1760 09

Label for Gabapentin 300 mg capsules, quantity of 30, repackaged by RemedyRepack Inc. The label includes the NDC number 70518-1760-09, manufacturer Ascend Labs, LLC, and storage instructions recommending 20-25°C with permitted excursions to 15-30°C. Directions for use refer to the package insert.*

FDA Label Image

Remedy_label (Remedy Label)

Gabapentin 300 mg oral capsules label by RemedyRepack Inc. The label shows the product name Gabapentin, strength 300 mg, dosage form capsule, and quantity of 30 capsules. The label includes NDC 70518-1760-00 and manufacturer information for Ascend Labs, LLC. Directions advise referring to the package insert for use, with storage instructions at 20-25°C. The label indicates the product is Rx only.*

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

A formula depiction illustrating the calculation for creatinine clearance (CLCr), involving age in years, weight in kilograms, and serum creatinine in mg/dL, with a multiplication factor for female patients. The text is presented in a scientific format within a United States prescription drug context.*

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

A line graph comparing mean pain scores over an 8-week period between a placebo group and a Gabapentin 3600 mg/day group. The x-axis shows weeks divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis represents the mean pain score. Gabapentin shows a steady decline in pain scores, while placebo remains relatively constant.*

FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

A line graph showing mean pain score changes over seven weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents time in weeks from baseline, and the y-axis shows mean pain scores from 0 to 10. The chart includes a 3-week dose titration period and a 4-week fixed dose period.*

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing Study 1 and Study 2 results. It shows percentages of responders for placebo (PBO) and Gabapentin (GBP) at different doses: Study 1 with PBO at 12% and GBP 3600 mg at 29%, and Study 2 with PBO at 14%, GBP 1800 mg at 32%, and GBP 2400 mg at 34%. Statistical significance is indicated with p-values of less than 0.01 and 0.001.*

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

This chart depicts the percentage difference in relation to daily doses (mg) of gabapentin from three separate studies, labeled as Study a, Study b, and Study c. The percentage difference is plotted on the vertical axis, while daily gabapentin dose in milligrams is shown on the horizontal axis, ranging from approximately 600 mg to 1800 mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.